- Previous Close
51,900.00 - Open
53,000.00 - Bid 50,800.00 x --
- Ask 55,800.00 x --
- Day's Range
50,700.00 - 53,300.00 - 52 Week Range
31,000.00 - 98,500.00 - Volume
81,652 - Avg. Volume
147,672 - Market Cap (intraday)
542.544B - Beta (5Y Monthly) 1.34
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 21, 2025 - Feb 25, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 27, 2018
- 1y Target Est
92,000.00
Cosmecca Korea Co., Ltd. engages in the research and development, manufacture, and sale of skincare products in South Korea and internationally. It offers skincare products, including lotion/toner, cream, essence, cleansers, Korean herbal products, mask sheet, scalp care, home scents, body and bath, exfoliators, and treatment products, as well as products for men, babies, and children; functional skincare products, which includes brightening, wrinkle and fine line, UV blocks/sunscreen, tanning, multi-functional, hair and body, and acne care products; and makeup products, such as BB and CC cream, skin cover balms, makeup base, foundation, concealer, lipstick, mascara, eyeliner, eyeshadow, blush/highlighter, and powders. The company was incorporated in 1999 and is headquartered in Eumseong-eup, South Korea.
www.cosmecca.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 241710.KQ
View MorePerformance Overview: 241710.KQ
Trailing total returns as of 2/7/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 241710.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 241710.KQ
View MoreValuation Measures
Market Cap
542.54B
Enterprise Value
603.08B
Trailing P/E
15.22
Forward P/E
19.05
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.05
Price/Book (mrq)
2.69
Enterprise Value/Revenue
1.16
Enterprise Value/EBITDA
7.65
Financial Highlights
Profitability and Income Statement
Profit Margin
6.77%
Return on Assets (ttm)
8.62%
Return on Equity (ttm)
18.61%
Revenue (ttm)
508.49B
Net Income Avi to Common (ttm)
34.45B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
48.14B
Total Debt/Equity (mrq)
41.21%
Levered Free Cash Flow (ttm)
-501.06M